Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.74 USD | +1.77% | -5.79% | +596.46% |
May. 31 | Piper Sandler Starts Elevation Oncology With Overweight Rating, $10 Price Target | MT |
May. 14 | Stephens Starts Elevation Oncology With Overweight Rating, $8 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+596.46% | 201M | |
+18.00% | 123B | |
+14.78% | 107B | |
-4.35% | 24.01B | |
+2.18% | 22.59B | |
-10.09% | 18.16B | |
-41.04% | 16.84B | |
-11.93% | 16.23B | |
+2.56% | 13.43B | |
+25.76% | 11.32B |
- Stock Market
- Equities
- ELEV Stock
- News Elevation Oncology, Inc.
- Elevation Oncology Appoints David Dornan as Chief Scientific Officer